PMV Pharmaceuticals, Inc. - COMMON STOCK (PMVP)

CUSIP: 69353Y103

Q1 2022 13F Holders as of 31 Mar 2022

Type / Class
Equity / COMMON STOCK
Shares outstanding
53,185,766
Total 13F shares
55,249,345
Share change
+7,872,487
Total reported value
$1,150,065,944
Put/Call ratio
77%
Price per share
$20.82
Number of holders
98
Value change
+$162,099,243
Number of buys
48
Number of sells
47

Quarterly Holders Quick Answers

What is CUSIP 69353Y103?
CUSIP 69353Y103 identifies PMVP - PMV Pharmaceuticals, Inc. - COMMON STOCK in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of PMV Pharmaceuticals, Inc. - COMMON STOCK (PMVP) as of Q1 2022

As of 31 Mar 2022, PMV Pharmaceuticals, Inc. - COMMON STOCK (PMVP) was held by 98 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 55,249,345 shares. The largest 10 holders included ORBIMED ADVISORS LLC, MORGAN STANLEY, RTW INVESTMENTS, LP, BOXER CAPITAL, LLC, INTERWEST VENTURE MANAGEMENT CO, JPMORGAN CHASE & CO, VANGUARD GROUP INC, BlackRock Inc., STATE STREET CORP, and Euclidean Capital LLC. This page lists 98 institutional shareholders reporting positions in this security for the Q1 2022 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.